NCT06664775View on ClinicalTrials.gov

A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery

PHASE3RecruitingINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

April 2, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

June 30, 2026

Conditions
Hemorrhage
Interventions
BIOLOGICAL

TachoSil

Adjunct to hemostasis

BIOLOGICAL

Surgicel Original

Adjunct to hemostasis

Trial Locations (9)

20007

RECRUITING

Georgetown University, Washington D.C.

28203

RECRUITING

Atrium Health Carolinas Medical Center, Charlotte

40202

RECRUITING

University of Louisville, Louisville

43210

RECRUITING

The Ohio State University Medical Center, Columbus

46202

RECRUITING

Indiana University, Indianapolis

60637

RECRUITING

University Of Chicago, Chicago

63110

RECRUITING

Washington University, St Louis

80228

RECRUITING

St. Anthony Hospital, Lakewood

90505

RECRUITING

Torrance Memorial, Torrance

Sponsors

Lead Sponsor

Corza Medical GmbH
All Listed Sponsors
lead

Corza Medical GmbH

INDUSTRY

NCT06664775 - A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery | Biotech Hunter | Biotech Hunter